Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Clinical Response and Tolerability of Selinexor in Acute Myeloid Leukemia and Other Hematologic Malignancies - a Systematic Review

Muhammad Junaid Tariq, MD, Muhammad Yasir, MD, Amna Khalid, MD, Saher Nasir Amin, MD, Sharoon Samuel, MBBS, Muhammad Jahanzeb Khalil, MD, Shehroz Aslam, MD, Malik Qistas Ahmad, MD MBBS, Muhammad Asad Fraz, MD, Muhammad Usman, MD, Awais Ijaz, MD, Arafat Ali Farooqui, MBBS, Seren Durer, MD, Ceren Durer, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5231.

https://doi.org/10.1182/blood-2018-99-116819

Published: 2018

Journal Articles

Promising Clinical Efficacy and Toxicity Profile of Isatuximab Based Regimens for Treatment of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: A Systematic Review

Zunairah Shah, MBBS, Madeeha Shafqat, Faiza Jamil, MD, Mustafa Nadeem Malik, MD, Abdul Rafae, MD, Shehroz Aslam, MD, Anum Qureshi, Maryam Sadiq, MBBS, Muhammad Abu Zar, MD, Ahmad Kamal, MD, Insija Ilyas Selene, MBBS, Sharoon Samuel, MBBS, Rida Riaz, MBBS, Midhat Lakhani, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 1949.

https://doi.org/10.1182/blood-2018-99-110243

Published: 2018

Journal Articles

Clinical Efficacy of Intracellular Molecular Inhibitors for Relapsed, Refractory Multiple Myeloma: A Systematic Review of Early Clinical Data

Shehroz Aslam, MD, Mustafa Nadeem Malik, MD, Abdul Rafae, MD, Rida Riaz, MBBS, Muhammad Jahanzeb Khalil, MD, Faisal Mahfooz, MD, Madeeha Shafqat, Anum Qureshi, Insija Ilyas Selene, MBBS, Syed Shabee Hassan, MD, Muhammad Junaid Tariq, MD, Muhammad Yasir, MD, Sharoon Samuel, MBBS, Maryam Sadiq, MBBS, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 1950.

https://doi.org/10.1182/blood-2018-99-111587

Published: 2018

Journal Articles

A Decade of Anti-Myeloma Vaccine Development through Early Phase Trials: A Systematic Review

Nadia Carenina Nunes Cavalcante Parr, MD, Muhammad Junaid Tariq, MD, Muhammad Usman, MD, Muhammad Asad Fraz, MD, Ali Younas Khan, MD, Sharoon Samuel, MBBS, Awais Ijaz, MD, Malik Qistas Ahmad, MD MBBS, Muhammad Jahanzeb Khalil, MD, Muhammad Yasir, MD, Saher Nasir Amin, MD, Ahmad Safdar, Abdul Rafae, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5635.

https://doi.org/10.1182/blood-2018-99-115922

Published: 2018

Journal Articles

Efficacy and Toxicity Profile of Elotuzumab for Multiple Myeloma: A Systematic Review and Meta-Analysis

Faiza Jamil, MD, Madeeha Shafqat, Sharoon Samuel, MBBS, Zunairah Shah, MBBS, Ceren Durer, MD, Seren Durer, MD, Maryam Sadiq, MBBS, Muhammad Junaid Tariq, MD, Jemin Aby Jose, MD, Warda Faridi, MD, Mohamed Mokhtar Bakr, MD, Umar Zahid, MD, Ali McBride, PharmD, MS, Ahmad Safdar, BS, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5640.

https://doi.org/10.1182/blood-2018-99-117209

Published: 2018

Journal Articles

Efficacy and Safety of Newer Targeted Immunotherapy for Multiple Myeloma

Shehroz Aslam, MD, Rida Riaz, MBBS, Mustafa Nadeem Malik, MD, Abdul Rafae, MD, Warda Faridi, MD, Saad Ullah Malik, MD, Insija Ilyas Selene, MBBS, Zunairah Shah, MBBS, Chaudhry Saad Sohail, MD, Faisal Mahfooz, MD, Sharoon Samuel, MBBS, Muhammad Yasir, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5650.

https://doi.org/10.1182/blood-2018-99-110233

Published: 2018

Journal Articles

Concomitant Use of Blinatumomab and Donor Lymphocyte Infusion for Post-Transplant Relapsed CD19 Positive Acute Lymphoblastic Leukemia: Systematic Review

Ceren Durer, MD, Seren Durer, MD, Madeeha Shafqat, Zunairah Shah, MBBS, Maryam Sadiq, MBBS, Muhammad Asad Fraz, MD, Malik Qistas Ahmad, MD MBBS, Hafiz Muhammad Fazeel, MD, Sharoon Samuel, MBBS, Mustafa Nadeem Malik, MD, Midhat Lakhani, MD, Chaudhry Saad Sohail, MD, Anum Qureshi, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5742.

https://doi.org/10.1182/blood-2018-99-109998

Published: 2018

Journal Articles

Antibodies in Development for Multiple Myeloma: A Systematic Review

Muhammad Asad Fraz, MD, Muhammad Junaid Tariq, MD, Muhammad Usman, MD, Nadia Carenina Nunes Cavalcante Parr, MD, Awais Ijaz, MD, Malik Qistas Ahmad, MD MBBS, Muhammad Yasir, MD, Seren Durer, MD, Muhammad Jahanzeb Khalil, MD, Ceren Durer, MD, Sharoon Samuel, MBBS, Saher Nasir Amin, MD, Ahmad Safdar, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5656.

https://doi.org/10.1182/blood-2018-99-114224

Published: 2018

Journal Articles

A Single Center Retrospective Evaluation of Daratumumab Infusion Related Reactions with Split-First Dose Day 1 and Day 2 Infusion

Ali McBride, PharmD,MS, Muhammad Usman, MD, Muhammad Jahanzeb Khalil, MD, Muhammad Junaid Tariq, MD, Muhammad Asad Fraz, MD, Awais Ijaz, MD, Malik Qistas Ahmad, MD MBBS, Ali Younas Khan, MD, Sharoon Samuel, MD, Insija Ilyas Selene, MBBS, James Camamo, Cara Chang, PharmD, Jemin Aby Jose, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5667.

https://doi.org/10.1182/blood-2018-99-119736

Published: 2018

Journal Articles

Efficacy and Safety of Histone Deacetylase Inhibitors in Multiple Myeloma - a Systematic Review of Early Phase Clinical Trials

Sharoon Samuel, MBBS, Muhammad Junaid Tariq, MD, Muhammad Usman, MD, Amna Khalid, MD, Muhammad Asad Fraz, MD, Awais Ijaz, MD, Faiza Jamil, MD, Muhammad Yasir, MD, Malik Qistas Ahmad, MD MBBS, Muhammad Jahanzeb Khalil, MD, Shehroz Aslam, MD, Madeeha Shafqat, Ceren Durer, MD, Zunairah Shah, MBBS, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5629.

https://doi.org/10.1182/blood-2018-99-114019

Published: 2018

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Clinical Response and Tolerability of Selinexor in Acute Myeloid Leukemia and Other Hematologic Malignancies - a Systematic Review

Promising Clinical Efficacy and Toxicity Profile of Isatuximab Based Regimens for Treatment of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: A Systematic Review

Clinical Efficacy of Intracellular Molecular Inhibitors for Relapsed, Refractory Multiple Myeloma: A Systematic Review of Early Clinical Data

A Decade of Anti-Myeloma Vaccine Development through Early Phase Trials: A Systematic Review

Efficacy and Toxicity Profile of Elotuzumab for Multiple Myeloma: A Systematic Review and Meta-Analysis

Efficacy and Safety of Newer Targeted Immunotherapy for Multiple Myeloma

Concomitant Use of Blinatumomab and Donor Lymphocyte Infusion for Post-Transplant Relapsed CD19 Positive Acute Lymphoblastic Leukemia: Systematic Review

Antibodies in Development for Multiple Myeloma: A Systematic Review

A Single Center Retrospective Evaluation of Daratumumab Infusion Related Reactions with Split-First Dose Day 1 and Day 2 Infusion

Efficacy and Safety of Histone Deacetylase Inhibitors in Multiple Myeloma - a Systematic Review of Early Phase Clinical Trials

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only